Nanomedicine News

RSS

New Microcapsules Could Help Stomach Absorb Certain Medicines

Finding ways to improve the stomach's uptake of poorly soluble medicines has been one of the major challenges facing pharmaceutical companies. Estimates suggest, for instance, that 40 percent of potential new drugs fall into this category.

27 May 2009

DFG to Establish Nine New Collaborative Research Centres from Cancer Research to Statistical Models

Effective 1 July 2009, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish nine new Collaborative Research Centres. This decision has just been made by the responsible Grants Committee of the DFG at its spring session in Bonn.

27 May 2009

Nanophotovoltaic Devices May Provide Novel Therapeutic Action

Spire Corporation (Nasdaq: SPIR), a global solar company providing turnkey solar factories and capital equipment to manufacture photovoltaic modules worldwide, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,514,725 B2 entitled "Nanophotovoltaic Devices."

27 May 2009

Tool Offers Business and Marketing Managers a Real and Comprehensive Picture of Microfluidics Community

Research and Markets, leading source for international market research and market data, has announced the addition of the "World Microfluidic Players Database" directory to their offering. This new tool off...

27 May 2009

Unique Translational Model Focuses on the Disease, Drug Targets and Clinical Development

Stand Up To Cancer (SU2C), the Entertainment Industry Foundation's charitable initiative supporting groundbreaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, has reached a significant milestone, awarding the first round of three-year grants - that total $73.6 million - to five multi-disciplinary, multi-institutional research Dream Teams.

27 May 2009

Aphios to Present Results of Phase II/III Clinical Trial of Zindol for Cancer Chemotherapy Induced Nausea

Aphios Corporation, a biotechnology company that is developing enabling technology platforms including nanotechnology drug delivery platforms such as phospholipid nanosomes, biodegradable polymer nanospheres, and protein...

26 May 2009

Complete Genomics Wins 2009 Red Herring 100 North America Award

Complete Genomics, Inc., a California company that has developed a novel approach to sequencing human DNA, today announced that it has been selected as a 2009 Red Herring 100 North America award winner. Founded in 20...

26 May 2009

RainDance Technologies Receives First European Order for Sequence Enrichment Solution

RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced it has received the first European order for its Sequence Enrichment Solution from ATLAS Biolabs GmbH of Berlin, Germany, a leading genomic services provider.

From Bio-Rad Laboratories India Pvt. Ltd. 26 May 2009

Affordable Layered Security Solutions for Protecting Packaging from Counterfeiting

Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion, has developed sustainable, "green" and affordable layered security solutions for protecting packaging from counterfeiting, piracy and fraud.

26 May 2009

New Funding Could Lead to Development of New and Better Treatments for Broken Bones

Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) could lead to the development of new and better treatments for broken bones and other orthopaedic problems associated with ageing.

26 May 2009

Nanomedicine News

New Microcapsules Could Help Stomach Absorb Certain Medicines

DFG to Establish Nine New Collaborative Research Centres from Cancer Research to Statistical Models

Nanophotovoltaic Devices May Provide Novel Therapeutic Action

Tool Offers Business and Marketing Managers a Real and Comprehensive Picture of Microfluidics Community

Unique Translational Model Focuses on the Disease, Drug Targets and Clinical Development

Aphios to Present Results of Phase II/III Clinical Trial of Zindol for Cancer Chemotherapy Induced Nausea

Complete Genomics Wins 2009 Red Herring 100 North America Award

RainDance Technologies Receives First European Order for Sequence Enrichment Solution

Affordable Layered Security Solutions for Protecting Packaging from Counterfeiting

New Funding Could Lead to Development of New and Better Treatments for Broken Bones

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting